Business Wire

Pragmatic Welcomes HRH The Princess Royal to Pragmatic Park for the Opening of the UK's First 300mm Semiconductor Wafer Manufacturing Facility

Share

Today, Pragmatic Semiconductor was honoured to welcome HRH The Princess Royal to officially open the UK’s first 300mm semiconductor wafer fabrication line (fab) at Pragmatic Park in Durham. The advanced manufacturing facility produces chips based on Pragmatic’s innovative and unique flexible integrated circuit technology. HRH The Princess Royal was hosted by David Moore, CEO, Pragmatic Semiconductor, with a tour of the clean room and facilities, followed by an unveiling of a site plaque to mark the occasion. Attendees included key customers, ecosystem partners, investors and government officials.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240327583783/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The UK’s first 300mm semiconductor fabrication line at Pragmatic Park, Durham, UK (Photo: Business Wire)

Pragmatic’s FlexICs are low-cost, more sustainable alternatives to silicon chips, ultra-thin, with a flexible form factor they enable connect, sense and compute capabilities, fuelling the Internet of Things (IoT) across multiple sectors including consumer, industrial, healthcare and beyond. The company’s mission is to provide item level intelligence to trillions of smart objects over the next decade across a wide range of applications with significant opportunities in smart packaging of fast-moving consumer goods that will significantly improve levels of reuse and recycling, transforming waste management, and enabling a circular economy. Other use cases include wearables, sensors and flexible controllers.

Pragmatic Park has capacity to host up to nine fabrication lines, each capable of producing billions of chips per year. Pragmatic’s pioneering sustainable approach extends to its manufacturing, using fewer process steps and a more concentrated footprint, than standard silicon fabs. The company’s innovative, optimised manufacturing process supports extremely rapid production cycles of less than 48 hours, at very low cost. The manufacturing process also uses significantly less energy and less water than typical silicon manufacturing, and fewer harmful gases. Pragmatic’s modular ‘Fab-in-a-Box’ approach, supports co-location of end-to-end FlexIC manufacturing at customers sites, rationalising extended supply chains and providing additional levels of security and resilience. The manufacturing facility enables the company to meet the growing demand for its unique technology from customers worldwide. Over the next five years Pragmatic anticipates creating over 500 highly skilled jobs in the North-East of England and Cambridge.

Dave Moore, CEO, Pragmatic Semiconductor said: "Today’s official opening marks a key milestone in Pragmatic’s growth trajectory and for the UK on the global semiconductor stage. I am incredibly proud of what the team has achieved and the ambition of our mission to enable item level intelligence in over a trillion sustainable, smart items over the next decade. Such intelligence at scale has the power to accelerate the digital transformation across industries. Sustainability is at the very core of our technology and extends to how FlexICs enable our customers to further drive innovations and pathways through their products and services towards global net zero goals.”

Francisco Melo, President Solutions Group, Avery Dennison said: “The key to any effective collaboration is a shared mindset. Pragmatic’s innovative approach is reflective of our own, as is its commitment to helping solve business challenges. The opening of an advanced manufacturing chip facility is fantastic news for all technology innovators. Congratulations to Pragmatic on such an important and impressive achievement. I look forward to our clients harnessing the potential of Pragmatic's flexible integrated circuits as part of our evolving inlay portfolio."

Simon Little, Banking & Investments Director, UKIB and Pragmatic Board member said: “The Bank invested in Pragmatic to support low carbon domestic manufacturing of semiconductors in the UK. The official opening of Pragmatic Park in Durham marks a pivotal next step in its journey, and we look forward to seeing the long-term impact of our investment, as Pragmatic scales up its operation and creates highly skilled jobs here in the North-East.”

Niranjan Sirdeshpande, Global Head of M&G’s Catalyst strategy and Pragmatic Board member said: “The UK has a very supportive ecosystem for providing early-stage funding, but it becomes challenging for businesses looking for later stage capital. By providing growth equity to enterprising tech disruptors such as Pragmatic, M&G’s £5 billion Catalyst strategy can help them to scale, provide expertise and partner with them all the way to success. Put to work in this way, patient capital can support economic growth and capture value for peoples' pensions and savings as we transition to a more sustainable economy. We are proud to support Pragmatic’s work in Durham with tech advancement in this critical part of the UK's national infrastructure.”

About Pragmatic Semiconductor

Pragmatic is revolutionising semiconductor fabrication with ultra-low-cost, flexible integrated circuit (FlexIC) technology that makes it quick and easy to embed intelligence almost anywhere.

With rapid cycle times that substantially accelerate time to market, its foundry provides high-volume fabrication at a fraction of the cost of silicon, with a significantly lower environmental impact.

www.pragmaticsemi.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Helen Ledger, SVP of Corporate Marketing, Communications and Public Affairs,  PR@pragmaticsemi.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

1NCE Continues Growth and Expands Its Software, AI and Services Offering7.1.2026 15:15:00 EET | Press release

1NCE, a company offering a plug-and-play platform for creating and managing the world’s best IoT products, reports another strong growth year, adding another 10 million endpoints. The company now manages 40+ million intelligent products for 30,000+ customers across 17 industries. 1NCE’s software and connectivity platform has become a new industry standard, delivering hassle-free IoT in 170+ countries and regions. The company has a unique vantage point in the IoT ecosystem, with four billion data records per day collected through 250+ streams on the world’s largest IoT network in the cloud. The company launched a new intelligent data program called 1NCE Insights. The program is part of the company’s goal of fusing AI + IoT intelligence to drive game-changing results in supply chains, smart cities, utilities and beyond. Customer-collected data is theirs and theirs alone. But with Insights, 1NCE opens access to its anonymized, networkwide data. Customers can benchmark their IoT projects a

Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking7.1.2026 15:00:00 EET | Press release

Prudentia Sciences, a pioneer in AI-native due diligence for life sciences dealmaking, today announced that it has secured $20 million in Series A financing. The round was led by McKesson Ventures with participation from SignalFire. Existing investors include Iaso Ventures, Virtue and GV. This brings the company’s total funding to $27 million, following a $7 million seed round in 2024. Prudentia Sciences provides an AI-native platform that enables pharma companies, biotechs, and financial institutions to evaluate breakthrough medicines with unprecedented speed and rigor. By synthesizing complex clinical signals into actionable insights, Prudentia accelerates deal throughput and provides strategic leverage for acquisition, licensing, or investment decisions made by business development, investment, and diligence teams. The company’s human-in-the-loop approach orchestrates seamless collaboration between buyers, sellers, and intermediaries. This ensures a secure, compliant infrastructure

Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD7.1.2026 13:30:00 EET | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for COMP360, enabling the initiation of a late-stage clinical trial in patients with PTSD. Compass management, along with KOL and industry leaders, will host a webinar today to discuss the company’s clinical trial plans for PTSD, as well as commercial preparations for treatment-resistant depression (TRD) from 10:00-11:30 am ET on January 7th. “PTSD is one of the most challenging mental health conditions, with approximately 13 million adults in the U.S. living with persistent symptoms and limited treatment options,” said Dr. Guy Goodwin, Chief Medical Officer at Compass Pathways. “We are pleased to advance our clinical development - the unmet need is profound, and it demands bold innovation. We believe COMP360 has the potential to tra

Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 12:07:00 EET | Press release

Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,

ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 11:00:00 EET | Press release

CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye